A Kentucky widow’s dangerous drugs lawsuit will join other claims in the Byetta Pancreatic Cancer multidistrict litigation (“MDL”). The most recent lawsuit names as defendants Amylin Pharmaceuticals and Eli Lilly & Co and alleges that the wrongful death of her husband was caused by his use of dangerous drug Byetta. The Byetta Pancreatic Cancer MDL is venued in the Southern District of California.
In her suit, Linda C. Plano, the plaintiff, claims that her husband used Byetta from the time it was prescribed to him in 2009 until 2012 when he learned of the potential for the dangerous drugs to cause pancreatic cancer. Sadly, even though Mr. Plano stopped using the drug in 2012, he was diagnosed with pancreatic cancer in 2013 and died within a few months of his diagnosis.
Mrs. Plano’s lawsuit also claims that had he known of the dangerous side effects of Byetta, her husband would have never taken the medication. Her suit alleges negligence, false advertising, concealing information and misrepresentation of the product by Amylin Pharmaceuticals and Eli Lilly & Co, the drugmakers.
Byetta has been marketed in the United States since it was approved by the U.S. Food and Drug Administration in 2005. Studies have linked use of Byetta to development of pancreatic cancer since 2011. Research indicates that users of Byetta are nearly three times more likely to develop pancreatic cancer than diabetics who do not use Byetta. Despite the evidence, the drug label does not warn of this dangerous potential side effect and the drug remains on the market.
The Ohio Pharmaceutical Injury Attorneys at Clark, Perdue & List have successfully represented hundreds of individuals with personal injury and wrongful death claims against numerous pharmaceutical and medical device manufacturers. If you or a loved one has been diagnosed with pancreatic cancer and you believe the disease was caused by Byetta, call Clark, Perdue & List.